Medical Laboratories in
Epalinges

Novigenix SA

Since 2014 · 21–50 empl.

The core activity of Novigenix is the development and application of precision medicine solutions, particularly in the field of cancer early detection and treatment, using liquid biopsy technologies and artificial intelligence (AI) based analysis platforms, such as the LITOSeek platform. The company focuses on researching and developing innovative approaches to cancer treatment, including the identification of new target molecules for drugs and the development of precision medicine approaches for personalized cancer treatment.

Swiss Nutrition and Health Foundation (SNHf)

Since 2003 · 1–10 empl.·3.0(6)

The core activity of the company "Swiss Nutrition and Health Foundation" includes conducting medical analyses, particularly in the field of nutrition and health, as well as certifying dietary supplements and other products. The company also provides consulting services to the industry, particularly to companies in the health and nutrition sector, and supports the development of new products and services. Furthermore, the company is engaged in research and development in the field of nutrition and health and offers a comprehensive range of services for measuring nutritional status and developing strategies for healthy nutrition.

Genesupport SA, succursale du canton de Vaud

Since 2020 · 1–10 empl.·3.0(4)

Genesupport SA, succursale de Lausanne is a competence centre in genetics. Services include diagnostic and screening genetic tests, genetic counselling, and medical/oncogenetic consultations for patients and healthcare professionals.

Novigenix AI SA

Since 2025 · 1–10 empl.

Novigenix AI SA develops liquid biopsy and multi-omics solutions based on the LITOSeek™ platform for immuno-transcriptomics analysis. The company uses AI and RNA data to discover biomarkers, predict therapy response, and support the development of cancer treatments.

ANABIOTEC, à Evergem, succursale de Epalinges (VD)

Since 2025 · 1–10 empl.

ANABIOTEC, à Evergem, succursale de Epalinges (VD) provides analytical services for drug development, with a focus on CMC analytics and (pre-)clinical bioanalysis. The company supports method development, method validation, stability studies, characterization studies, and release testing for synthetic, biological, and cell and gene therapy products.

Fondation de la Croix-Rouge, Service Régional Vaudois de Transfusion Sanguine CRS

Since 1994 · 1–10 empl.

Unilabs Pathologie SA, succursale d'Epalinges Cypa

Since 2012 · 1–10 empl.

VitalizeDx Sàrl

Since 2023 · 1–10 empl.